"At Urgent Care - Clemmons we provide the following care and services: Open weekends and evenings for walk-in appointments, On-site pharmacy available, On-site labs and routine X-rays, Minor office-based procedures and Referrals to Wake Forest Baptist Health specialists as needed."

During the past decade, Wake Forest University at Clemmons conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 1 clinical trials were completed, i.e. on average, 2.9% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 1 clinical trials were completed. i.e. 4.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wake Forest University at Clemmons" #1 sponsor was "National Cancer Institute (NCI)" with 23 trials, followed by "Wake Forest University Health Sciences" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored and "NRG Oncology" with 3 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest University at Clemmons" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Wake Forest University at Clemmons" are "Acute Myeloid Leukemia" (3 trials), "Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome" (3 trials), "Clinical Stage IV Cutaneous Melanoma AJCC v8" (3 trials), "Therapy-Related Acute Myeloid Leukemia" (3 trials) and "Acral Lentiginous Melanoma" (2 trials). Many other conditions were trialed in "Wake Forest University at Clemmons" in a lesser frequency.

Most popular intervention types in "Wake Forest University at Clemmons" are "Drug" (28 trials), "Other" (19 trials), "Biological" (18 trials), "Procedure" (18 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (16 trials), "Computed Tomography" (14 trials), "Magnetic Resonance Imaging" (10 trials), "Nivolumab" (8 trials) and "Biopsy" (7 trials). Other intervention names were less common.

The vast majority of trials in "Wake Forest University at Clemmons" are 30 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Wake Forest University at Clemmons". undefined are not yet recruiting, 18 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Wake Forest University at Clemmons, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Wake Forest University at Clemmons, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".